Astral Rbv published presentations and documents on DocSlides.
«Pass the . puck. » to Astral . TVPlus. !. 2004...
B. . CHEM. ENGG.. Part 2. . Cell Division. Dr. . ...
Loneliness and Isolation Evidence Review This evid...
ASTRAL-1. Phase 3. . Treatment. . Naïve & ...
Tandy Warnow. Joint work with . Siavash. . Mirar...
Flip-Top . table. . standard. . Foot . extensio...
HCV Genotype 3 and HIV/HCV Coinfection . What's S...
Planes Flip-Top Tables 2014 – September 5th Fli...
University of Illinois at Urbana-Champaign. http:/...
ELECTRON (Overview): 6 parts, 22 arms. Phase . 2....
thalassaemia. . Where . are we now?. Telaprevir ....
Developed by Camilla S. Graham, MD, BIDMC, 5/5/15...
Todd S. Wills, MD. SPNS HCV Treatment Expansion I...
SAFETY AND EFFICACY OF ABT-450/R/OMBITASVIR, DASA...
OBV/PTV/r . + . DSV . + RBV. OBV/PTV/r + . DSV . ...
Design. Open-label. CURRY . Study. : SOF + RBV fo...
With Or Without Ribavirin Is Safe and Efficacious...
1. Le 29-01-2015. Les anticorps neutralisants ant...
Marie-Louise Vachon, MD, . MSc. Division of . Inf...
B290. The object of strategic analysis…. Explai...
Paritaprevir. -. Ritonavir (. Technivie. ). Prepa...
SAPPHIRE-I. Phase 3. . Treatment. . Naïve. Fel...
+ DSV + RBV. No randomisation. Open-label. TOPAZ-...
OBV/PTV/r . + . DSV . + RBV. OBV/PTV/r + . DSV . ...
Genotype . 1 . (. Viral . Relapsers. ). PROMISE ....
Genotype . 2. . or 3 . FUSION. Trial. Phase . ...
Pegasys. ). Prepared by: David Spach, MD & H....
. and Dasabuvir +/- . RBV in . GT1b. PEARL-II. P...
3. Rd. International . HIV/Hepatitis . Coinfecti...
-. Ritonavir . and Dasabuvir . + RBV in . GT1. SA...
N = 100. W12. W24. Arm B: . compensated cirrhosis...
Harvoni. ). Prepared by: . David H. Spach, MD and...
With Or Without Ribavirin Is Safe and Efficacious...
OBV/PTV/r + RBV. Randomisation*. 1 : 1. Open labe...
N = 45. N = 49. W24. W16. MK3. > . 18 years. H...
W24. DCV + PR. Placebo + PR. Yes. Dore GJ. Gastro...
David Spach, MD. Clinical Director, Northwest AET...
. or 3 . LONESTAR-2. Phase 2. Treatment. . Exp...
Design. Objective. SVR. 12. (HCV RNA < 25 IU/...
-. 0938 in GT 1-4. QUANTUM. Phase . 2b. Treatment...
Copyright © 2024 DocSlides. All Rights Reserved